Abcam News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

17.11.23	Abcam-Danaher Deal Receives All Identified Clearances - Quick Facts (RTTNews)
23.10.23	Proxy Advisor Glass Lewis Recommends Abcam Shareholders To Vote 'for' Danaher Acquisition (RTTNews)
10.10.23	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AEL, HT, ABCM, ACER (PR Newswire)
19.09.23	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ABCM, AGE, ACER, NXGN (PR Newswire)
12.09.23	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SOVO, THRN, ABCM, CELL (PR Newswire)
06.09.23	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates THRN, ABCM, AGE, ACER (PR Newswire)
28.08.23	Danaher To Acquire Abcam In About $5.7 Bln All-cash Deal (RTTNews)
12.07.23	Abcam plc: All Resolutions Withdrawn at Abcam's EGM (PR Newswire)
05.07.23	ABCAM PLC: Trading Update (PR Newswire)
23.06.23	Abcam Rises 8% As It Explores Possible Sale (RTTNews)
23.06.23	Abcam To Initiate Process To Explore Strategic Alternatives, Including Potential Sale (RTTNews)
23.06.23	Abcam Announces Review of Strategic Alternatives (PR Newswire)
30.05.23	ABCAM PLC: Statement on calling an Extraordinary General Meeting (PR Newswire)
17.05.23	Abcam PLC: Statement on potential Extraordinary General Meeting (PR Newswire)
17.05.23	ABCAM PLC Result of Annual General Meeting (PR Newswire)
04.05.23	Abcam, plc Business Update (PR Newswire)
02.05.23	ABCAM PLC Comments on Investor Engagement (PR Newswire)
17.04.23	ABCAM PLC: Upcoming Abcam Investor Events (PR Newswire)
13.04.23	ABCAM PLC: Trading Update (PR Newswire)
30.03.23	Abcam, plc Publication of 2022 Annual Report and Accounts and Notice of Annual General Meeting (PR Newswire)
20.03.23	ABCAM PLC: Final results for the year ended 31 December 2022 (PR Newswire)
10.03.23	Abcam to Report Full Year Results on Monday, March 20, 2023 (PR Newswire)
30.01.23	ABCAM PLC: Trading Update (PR Newswire)
13.12.22	Pre-market Movers: ACMR, CNCE, MRTX, LEV, AMAM… (RTTNews)
12.12.22	Abcam plc: Update on AIM Delisting (PR Newswire)
29.11.22	Pre-market Movers: SNES, KALA, LEV, EBS, GHG… (RTTNews)
11.11.22	ABCAM PLC: Result of General Meeting - Shareholders approve AIM Delisting (PR Newswire)
17.10.22	ABCAM PLC: Proposed resolution for cancellation of AIM listing (PR Newswire)
12.09.22	ABCAM PLC: Interim results for the six-month period ended 30 June 2022 (PR Newswire)
20.07.22	ABCAM PLC First Half Trading Update (PR Newswire)
27.06.22	Abcam: Appointment of Vice President of Investor Relations (PR Newswire)
25.03.22	Abcam the most awarded company at 2022 industry awards (PR Newswire)
04.01.22	Alamar Biosciences partners with Abcam to drive understanding of the human proteome (PR Newswire)
02.11.21	Nautilus and Abcam Announce Strategic Partnership to Accelerate Exploration of the Proteome (PR Newswire)
27.10.21	Abcam completes $340m strategic acquisition and expands kit capacity and capability (PR Newswire)
13.07.21	Abcam opens new US facility in Boston, MA (PR Newswire)
13.07.21	Abcam opens new US facility in Boston, MA (PR Newswire)
22.06.21	Pionyr and Abcam extend partnership to evaluate TREM2-expressing cells in cancer patients (PR Newswire)
22.06.21	Pionyr and Abcam extend partnership to evaluate TREM2-expressing cells in cancer patients (PR Newswire)
13.11.20	Pre-market Movers In Healthcare Sector: UROV, NAVB, BNGO, DFFN, KROS… (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Abcam PLC (spons. ADRs)

Aktien Top/Flop

Meistgelesene Nachrichten